27–31 Oct 2025
InterContinental Chengdu Global Center
Asia/Shanghai timezone
The submission portal for presentation materials and papers is now open. Please submit your full paper before October 29.

The NHA C400 cyclotron facility for Hadron Therapy becomes a reality

THAI02
30 Oct 2025, 09:00
30m
InterContinental Chengdu Global Center

InterContinental Chengdu Global Center

Chengdu, China
Invited Oral Presentation Cyclotron and Technology Cyclotron for Hadron Therapy and Isotope Production (5)

Speaker

Gaelle Gerard (Ion Beam Applications (Belgium))

Description

The NHa C400 [1] is an isochronous cyclotron for cancer therapy which can deliver high intensity of alphas to carbons at 400 MeV/amu and protons at 260 MeV. It is the first cyclotron-based clinical carbon therapy solution worldwide characterized by K=1600, this is the strongest compact cyclotron. Most of the part of the cyclotron has been constructed and assembled as well as subsystems such: Super Conducting Coil, Yoke lifting system, Cryogenic System, External Injection System (EIS), etc… In parallel, Control Unit (CU) cabinets are fitted to the power room, cabled and tested to control subsystem hereabove. The EIS system is under trials at IBA / Louvain-la-Neuve, the functionalities of this system will be validated before its settle back to Cyclhad. Similarly, the mapping wheel dedicated to the magnetic field mapping of C400 is ready to leave IBA / Louvain-la-Neuve for be installed inside the C400 cyclotron and perform last final in-situ tests. Beside the construction and installation of subsystems, electrostatic deflector as well as beam probe are in the final stage of design before their production. The paper will present the status of all the components of the SRTH (Systeme de Recherche et Traitement en Hadrontherapy) machine with a focus on the actual assembly of C400 subsystems.

Footnotes

[1] J. Mandrillon et al., Proceedings of the 23rd International Conference on Cyclotrons and their Applications, 5-9 December 2022, Beijing, China

Author

Gaelle Gerard (Ion Beam Applications (Belgium))

Co-authors

Mr Alexandre Duval (Normandy Hadrontherapy) Mr Alexis Bonnemains (Normandy Hadrontherapy) Mr Arnaud Dumont (Ion Beam Applications (Belgium)) Mr Arnaud Duvivier (Ion Beam Applications (Belgium)) Mr Arthur Guillon (Normandy Hadrontherapy) Mr Batista Nsunda (Ion Beam Applications (Belgium)) Mr Benoit Barriaut (Normandy Hadrontherapy) Mrs Carole Lafitte (Normandy Hadrontherapy) Mr Christophe Lefoll (Normandy Hadrontherapy) Mrs Claire Leconte (Normandy Hadrontherapy) Mr Clément Bienvenu (Normandy Hadrontherapy) Mr Colin Guillaume (Ion Beam Applications (Belgium)) Mr Cosimo L'abbate (Ion Beam Applications (Belgium)) Mr Cyprien Vogels (Ion Beam Applications (Belgium)) Mr David Germain (Ion Beam Applications (Belgium)) Mr Dimitri Degeyter (Ion Beam Applications (Belgium)) Mr Dirk Doelling (Ion Beam Applications (Belgium)) Mr Eric Van Den Hove (Ion Beam Applications (Belgium)) Mr Farid Boulaayoun (Ion Beam Applications (Belgium)) Mr Florian Morel (Normandy Hadrontherapy) Mr Francois-Louis Laillier (Normandy Hadrontherapy) Frédéric Stichelbaut (Ion Beam Applications (Belgium)) Mr Geoffrey Lebrun (Ion Beam Applications (Belgium)) Mr Gianluca Yernault (Ion Beam Applications (Belgium)) Mr Gilles Goosse (Ion Beam Applications (Belgium)) Mr Guillaume Despont (Normandy Hadrontherapy) Mr Henry Austins (Normandy Hadrontherapy) Mr Idris Maubant (Normandy Hadrontherapy) Mrs Imane Masselis (Normandy Hadrontherapy) Jacob Kelly (Ion Beam Applications (Belgium)) Mr Jean Festy (Normandy Hadrontherapy) Mr Jean-Baptiste Jacquin (Normandy Hadrontherapy) Mr Jefferson Sorriaux (Normandy Hadrontherapy) Mr Jerome Hanot (Normandy Hadrontherapy) Jerome Mandrillon (Ion Beam Applications (Belgium)) Mr Jules Detobel (Ion Beam Applications (Belgium)) Mr Julien Beguin (Ion Beam Applications (Belgium)) Mr Julien Jourdain (Normandy Hadrontherapy) Mr Laurent Koffel (Ion Beam Applications (Belgium)) Laurent Maunoury (Normandy Hadrontherapy) Mr Louis-Edouard Vallee (Normandy Hadrontherapy) Marc De Leenheer (Normandy Hadrontherapy) Mr Marc Rouy-Beltran (Normandy Hadrontherapy) Mr Mathias Sergio (Normandy Hadrontherapy) Mr Maxime Dufour (Normandy Hadrontherapy) Mr Mehrdad Mostafavi (Ion Beam Applications (Belgium)) Mr Michael De Coninck De Merckem (Ion Beam Applications (Belgium)) Michel Abs (Ion Beam Applications (Belgium)) Mr Mihai Baja (Ion Beam Applications (Belgium)) Mr Mihaja Andrianarivony (Normandy Hadrontherapy) Mr Mikael Laisney (Normandy Hadrontherapy) Mr Nicolas Bakon (Normandy Hadrontherapy) Mr Oliver Gillessen (Ion Beam Applications (Belgium)) Olivier Cosson (Normandy Hadrontherapy) Mr Paulin Laronche (Normandy Hadrontherapy) Philippe Velten (Normandy Hadrontherapy) Mr Pierre Snappe (Ion Beam Applications (Belgium)) Mr Richard Borys (Normandy Hadrontherapy) Mrs Sarah Julien (Normandy Hadrontherapy) Mr Sebastien De Neuter (Ion Beam Applications (Belgium)) Mr Sebastien Deprez (Ion Beam Applications (Belgium)) Mr Sebastien Le Pivert (Normandy Hadrontherapy) Mr Thomas Michel (Normandy Hadrontherapy) Mr Vincent Engelen (Ion Beam Applications (Belgium)) Vincent Nuttens (Ion Beam Applications (Belgium)) Virgile Letellier (Normandy Hadrontherapy) Willem Kleeven (Ion Beam Applications (Belgium)) Mr Xavier Donzel (Ion Beam Applications (Belgium)) Mr Yohakim Otu (Ion Beam Applications (Belgium)) Yves Jongen (Ion Beam Applications (Belgium)) Mr Yves Paradis (Ion Beam Applications (Belgium))

Presentation materials

There are no materials yet.